Skip to content Skip to Search
Skip navigation

Mubadala to buy pharma company Kelix Bio

By Pramod Kumar
The acquisition of Kelix bio is set to boost the UAE’s global standing in life sciences, said Mubadala Kelix Bio
The acquisition of Kelix bio is set to boost the UAE’s global standing in life sciences, said Mubadala

Abu Dhabi’s Mubadala Investment Company has signed a definitive agreement to acquire Kelix Bio, a specialty pharmaceutical business in the UAE that focuses on delivering complex generics across emerging markets.

The Kelix Bio acquisition is set to boost the UAE’s global standing in life sciences, state-own Abu Dhabi Media Office reported, quoting a Mubadala statement.

Person, Electronics, Mobile Phone

Newsletter
Get the Best of AGBI delivered straight to your inbox every week

The stake was purchased from a consortium of investors, including Development Partners International, the UK’s development finance institution and impact investor British International Investment, and the European Bank for Reconstruction and Development.

No financial details were shared. The transaction is subject to regulatory approvals.

Kelix Bio was founded in November 2020 and has since acquired manufacturing businesses in India, Egypt, Malta and Morocco.

It has commercialised a wide range of oral and injectable formulations for diverse therapy areas, including diabetes, oncology, cardiology and central nervous systems.

Dr Bakheet Al Katheeri, CEO of Mubadala’s UAE Investments Platform, said the purchase would advance Mubadala’s position in the life sciences sector and deliver long-term socio-economic returns, including improved healthcare, drug security, job creation and GDP impact.

According to research from investment banking advisory firm Alpen Capital, healthcare spending in the GCC region is set to reach $135.5 billion in 2027, implying annual growth of 5 percent from $104 billion last year.

Latest articles

STC wants to consolidate the mobile tower market

STC approves PIF purchase of telecom company

Shareholders of Saudi telecom giant STC have approved plans to create a new telecommunications infrastructure company in which the Public Investment Fund will have a 51 percent stake valued at SAR8.7 billion ($2.3 billion).  Under the deal, the STC-owned Telecommunication Towers Co. Limited (Tawal) will become a PIF subsidiary through a merger with Golden Lattice […]

Flavio Cattaneo of Enel, of which Endesa is a subsidiary, and Mohamed Jameel Al Ramahi at the signing of the deal

Masdar buys stake in Spanish utilities company Endesa

The UAE’s state-owned clean energy company Masdar has agreed to acquire a minority stake in Spanish electric utility business Endesa to partner for 2.5 gigawatts (GW) of renewable energy assets in Spain. Under the agreement, subject to regulatory approval, Masdar will invest nearly $890 million to acquire a 49.99 percent stake in Endesa, with an […]

UAE markets Hong Kong

UAE capital markets partner with Hong Kong exchange

The Hong Kong Stock Exchange (HKSE) has added the Abu Dhabi Securities Exchange (ADX) and the Dubai Financial Market (DFM) to its roster of recognised marketplaces. The move opens the door for UAE-based companies to pursue secondary listings on one of Asia’s premier financial markets. It also follows the inclusion of the Saudi Exchange (Tadawul) […]

Person, Worker, Adult

Aramco and PIF invest in Saudi-Chinese steel venture

Saudi Aramco and the Public Investment Fund have doubled their investment in a steel plate joint venture with a Chinese company to $500 million. The two Saudi companies each own 25 percent shares in the new venture in Ras Al Khair industrial city, Bloomberg reported, quoting a statement published on the Chinese stock exchange. Chinese […]